Citations

ABSTRACT HLA‐C*01:155 is characterised by a single nucleotide substitution in codon 225 in exon 4.

ABSTRACT The novel HLA‐A*26:268 allele is characterised by a single nucleotide substitution in exon 7.

ABSTRACT HLA‐DPA1*03:25 is characterised by a single nucleotide substitution in codon 96 in exon 3.

ABSTRACT The novel HLA‐A*03:535 allele is characterised by a single nucleotide substitution in exon 1.

ABSTRACT HLA‐DQB1*03:609 is characterised by a single nucleotide substitution in codon 132 in exon 3.

ABSTRACT The HLA‐DQB1*03:506:01:01 allele is characterised by a single nucleotide substitution in codon 130 in exon 3.

ABSTRACT The HLA‐C*14:84 allele is characterised by a single nucleotide substitution in codon 181 in exon 3.

AbstractCurrent published guidelines for perioperative pharmacy services have limited information on the development and implementation of a robust clinical pharmacy program across the surgical continuum of care. This publication defines the responsibilities and scope of practice of the Perioperative Clinical Pharmacist (PCPh), supporting the PCPh as a critical member of the interprofessional surgical patient care team. Opportunities for pharmacist role integration into perioperative medication management processes are described along with published examples of successful PCPh practice models, including those with interventions targeted toward Enhanced Recovery Pathways (ERP). Recommended training and competencies for future and practicing perioperative pharmacists, in addition to considerations for precepting and scholarly activities, are also outlined. Finally, future developments in perioperative pharmacy practice are discussed, including technological advancements, improved predictive models, and expansion of collaborative practice agreements.